Autres langues Curis, Inc.

Actions

CRIS

US2312693094

Temps Différé Nasdaq Autres places de cotation 18:53:12 26/04/2024			Varia. 5j.	Varia. 1 janv.
14,52 ^USD	-0,00 %		+1,47 %	+13,88 %

09/02	CURIS, INC. : HC Wainwright toujours à l'achat	ZM
08/02	Curis, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Curis Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	08/04
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/04
Curis to Present at Upcoming Healthcare Conferences in April	04/04
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)	02/04
Curis Provides Fourth Quarter 2023 Business Update	09/02
Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/02
Curis: Q4 Earnings Snapshot	08/02
Earnings Flash (CRIS) CURIS Reports Q4 Revenue $2.7M, vs. Street Est of $3.1M	08/02
Curis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/02
Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024	01/02
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/01
Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study	12/12
Curis, Inc. Announces Initial Combination Study Data from Its Take Aim Lymphoma Study	12/12
Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference	11/12
Curis Enters into Agreement for Emavusertib, Pembrolizumab Combination Study in Melanoma	06/12
Curis Announces Three Presentations at ASH	06/12
Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma	05/12
Curis, Inc. Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma	05/12
Curis: Q3 Earnings Snapshot	02/11
Earnings Flash (CRIS) CURIS Posts Q3 Revenue $2.8M, vs. Street Est of $2.6M	02/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Curis, Inc.

Actions

CRIS

US2312693094

Autres langues

Filtres